Malaysia’s pharmaceutical and medical device needs for cardiology care are increasing due to rising rates of cardiovascular disease.

Using Digital Technology to Improve Adherence to Chronic Medication

Malaysia is a Southeast Asia oncology hub presenting opportunities for U.S. pharmaceuticals and medical device manufacturers specializing in oncology

U.S. healthcare solution providers should look at Singapore’s growing healthcare needs and redevelopment of two key National University Health System hospitals.

India’s changing healthcare sector and roadmap for improved hospitals and healthcare advancements fosters opportunities for U.S. businesses.

This healthcare snapshot summarizes trends in New Zealand’s public healthcare since the new National-led Government won the October 2023 election.

Despite competition, the Australian oral health market offers promise for U.S. firms due to population growth, aging population, and rising disposable incomes.

Colombia’s largest health insurance companies were placed under government control.

The European Commission has taken action in the past several weeks to tackle the PRC’s unfair market practices

A procurement agreement between the Ministry of Health and UNOPS increases competition and provides procurement opportunities to U.S. healthcare companies.

India presents significant opportunities for U.S. companies looking to leverage AI technologies.

The Singapore biotechnology market size was valued at $823.5 billion in 2021 according to Market Research Community and is expected to grow 8.0% yearly. 

The law creates a new autonomous agency responsible for authorizing processes needed by U.S. companies interested in selling their products in El Salvador.

Malaysia’s Digital Health market is undergoing growth and transformation.

Japan remains committed to fostering the development and commercialization of Software as a Medical Device (SaMD) through new government initiatives.